Floatz logo

Therapeutic Asset Ratings

414 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Hbi-2376
Colorectal Cancer
HUYABIO International, LLC.P1C (36)
Hbi-2438
Colorectal Cancer
HUYABIO International, LLC.P1C (36)
hfb200603
Colorectal Cancer
HiFiBiO TherapeuticsP1C (36)
H-gamma1 heavy chain humanized (1-449) [VH (Homo sapiens IGHV3-23*01 (81.6%) -(IGHD) -IGHJ3*02 (91.7%) M123>T (114), CDR-IMGT [8.7.13] (26-33.51-57.96-108)) (1-119) -Homo sapiens IGHG1*03v (100%) G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14 (CH1 R120>K (216) (120-217), hinge 1-15 (218-232), CH2 (233-342), CH3 E12 (358), M14 (360) (343-447), CHS (448-449)) (120-449)], (222-218')-disulfide with L-kappa light chain humanized (1'-218') [VKAPPA (Homo sapiens IGKV1-33*01 (87.8%) -IGKJ4*01 (100%), CDR-IMGT [6.3.13] (27'-32'.50'-52'.89'-101')) (1'-111')-Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPAA45.1 (157'), V101 (195')) (112'-218')]; dimer (228-228'':231-231'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1, glycoform alfa
Colorectal Cancer
Genentech, Inc.P1C (36)
hh160
Colorectal Cancer
Huahui HealthP1C (36)
hs-10370
Colorectal Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (36)
hs-10502
Colorectal Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (36)
hs-20093
Colorectal Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (36)
hs-20117
Colorectal Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (36)
ibi351
Colorectal Cancer
Innovent Biologics (Suzhou) Co. Ltd.P1C (36)
Icovamenib
Colorectal Cancer
Biomea Fusion Inc.P1C (36)
ide034
Colorectal Cancer
IDEAYA BiosciencesP1C (36)
Ide-161
Colorectal Cancer
IDEAYA BiosciencesP1C (36)
Ide-Cel
Colorectal Cancer
Dispatch BiotherapeuticsP1C (36)
Idov-Immune
Colorectal Cancer
ViroMissile, Inc.P1C (36)
ik-595
Colorectal Cancer
Ikena OncologyP1C (36)
im-1617
Colorectal Cancer
Immunome, Inc.P1C (36)
Imiquimod
Colorectal Cancer
Toray Industries, IncP1C (36)
imm2520
Colorectal Cancer
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.P1C (36)
Immunoglobulin G1 [de-C-terminal-lysine], anti-(human epidermal growth factor receptor) (human-Mus musculus clone BCA101 ?1-chain), disulfide with human-Mus musculus clone BCA101 ?-chain fusion protein with peptide linker (GGGGS)3 fusion protein with 23-159-transforming growth factor ? receptor TGFBR2 (human), dimer
Colorectal Cancer
Bicara TherapeuticsP1C (36)
immunoglobulin G1-kappa, anti-[Homo sapiens TIGIT (T-cell immunoreceptor with Ig domain and ITIM, V-set Ig member 9, VSIG9, V-set and transmembrane member 3, VSTM3)], humanized monoclonal antibody; gamma1 heavy chain humanized (1-448) [VH (Homo sapiens IGHV3-48*01 (90.8%) -(IGHD) -IGHJ4*01 (92.3%)) CDR-IMGT [8.8.12] (26-33.51-58.97-108) (1-119) -Homo sapiens IGHG1*01, G1m17,1, G1v14 CH2 A1.3, A1.2 (CH1 K120 (216) (120-217), hinge 1-15 (218-232), CH2 L1.3>A (236), L1.2>A (237) (233-342), CH3 D12 (358), L14 (360) (343-447), CHS K>del (448)) (120-448)], (222-214')-disulfide with kappa light chain humanized (1'-214') [V-KAPPA (Homo sapiens IGKV1-16*01 (89.5%) -IGKJ4*01 (100%)) CDR-IMGT [6.3.9] (27-32.50-52.89-97) (1'-107') -Homo sapiens IGKC*01 (100%) Km3 A45.1 (153), V101 (191) (108'-214')]; dimer (228-228'':231-231'')-bisdisulfide, produced in a Chinese hamster ovary (CHO)-K1 cell line, glycoform alfa
Colorectal Cancer
Taiho Pharmaceutical Co., Ltd.P1C (36)
Iodixanol
Colorectal Cancer
Thomas Jefferson UniversityP1C (36)
ivx037
Colorectal Cancer
ImmVirx Pty LtdP1C (36)
ix001 tcr-t cells
Colorectal Cancer
Shanghai Pudong HospitalP1C (36)
jr8603
Colorectal Cancer
JiaRay GroupP1C (36)
Showing 301 to 325 of 414 assets
PreviousPage 13 of 17Next